Abstract
Get full access to this article
View all access options for this article.
References
1.Subcommittee on Health, House Committee on Energy and Commerce , February 17 , 2011 . https://www.govinfo.gov/content/pkg/CHRG-112hhrg66467/pdf/CHRG-112hhrg66467.pdf
2.
Makower
J.
,
Meer
A.
, &
Denend
L.
2010 ) FDA Impact on U.S. Medical Technology Innovation . 44 pp. https://cdn.ymaws.com/www.medicaldevices.org/resource/resmgr/docs/FDA_impact_on_US_med_tech_in.pdf
3.
Herr
T.
, (2021 ) US FDA publishes EUA templates for COVID-19 IVD submissions . https://www.emergobyul.com/blog/2021/03/us-fda-publishes-eua-templates-covid-19-ivd-submissions
4.
Quinn
B.
(2022 ) Revisiting MCIT with Numbers. MCIT Could Triple the Value of Medtech Investments. Discoveries in Health Policy (blog) . http://www.discoveriesinhealthpolicy.com/2022/02/revisiting-mcit-with-numbers-mcit-could.html
5.
Goldfarb
A.
, &
Teodoris
F.
2022 ) Why is AI adoption in health care lagging? . Brookings Institute . https://www.brookings.edu/research/why-is-ai-adoption-in-health-care-lagging/
6.
Letai
A.
Functional precision cancer medicine – moving beyond pure genomics . Nature Medicine , 23 :1028 -35 . https://www.nature.com/articles/nm.4389ging/